Sociodemographic and Anthropometric Profile of People Living with Human Immunodeficiency Virus Starting Treatment in Kinshasa, Democratic Republic of the Congo

Losenga, Lambert Omombo; Dikati, Noella Makela; Bongenya, Berry Ikolango; Ntumba, Thérèse Kasaka; Booto, Grace Ipaya; Dembo, Rosalie Djamba; Selenge, Stéphanie Mauwa; Nonga, Jocelyn Ewuti; Kabamba, Candide About; Sombo, Marie-Thérèse Ayanne Safi; Bumoko, Guy Makila Mabe; Kamangu, Erick Ntambwe

doi:10.4236/oalib.1109056

Cited by 10 publications

(6 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The most found age group is between 36 to 45 years with 16 cases (26.7%), followed by the age group from 46 to 55 with 15 cases (25%), 26 to 35 years with 11 cases (18.3%), followed by 56 to 65 years old with 10 cases (16.7%) and finally the age group 18 to 25 years old with 8 cases (13.3%). This general observation is reported by several authors in our field [4] [5] [9].…”

Section: Discussionsupporting

confidence: 89%

“…The predominance of the female gender in the present study corroborates existing data. The majority of studies carried out in Kinshasa, in the Democratic Republic of Congo (DRC), or even in Central Africa mention this predominance of the female sex in the populations of PLHIV monitored [4] [5] [9].…”

Section: Discussionmentioning

confidence: 99%

“…During the M6 appointment, a sample of 5 ml of blood was taken for the various analyzes from all HIV patients included [4].…”

Section: Study Design Patient Setting and Samplesmentioning

confidence: 99%

See 2 more Smart Citations

Profile of People Living with HIV after 24 Weeks of Treatment with Dolutegravir in Kinshasa

Bongenya,

Kabengele,

Sombo

et al. 2023

AID

View full text Add to dashboard Cite

Introduction: The sixth month appointment (M6) is crucial because at the start of the ART course, it is an indicator of the prognosis of the evolution of care and decision-making on the continuity of treatment. Objective: The objective of this study is therefore to present the profile of People Living with HIV under treatment with Dolutegravir 6 months after starting ART in Kinshasa. Methods: The present study is a cross-sectional view at M6 of a prospective cohort to determine the profile of People Living with HIV (PLHIV) after 6 months of ARV Treatment (ART) in Kinshasa, DRC. During the M6 appointment, from April to August 2022, a sample of 5 ml of blood was taken for the various analyzes from all HIV patients included. The collection of sociodemographic data as well as biological and clinical data was carried out under the same conditions as at inclusion. The parameters recorded during M6 were: age, sex, and religion, level of study, marital status, profession, socio-economic level, height, weight, Body Mass Index (BMI), clinical profile, opportunistic infections as well as biochemical and molecular assessment. Results: In M6, 62 patients were registered including 38 women (61.3%), thus giving a sex ratio of 1.58 in favor of women. Fifty-seven (57) patients did not How to cite this paper: Bongenya, B.I.,

show abstract

Section: Discussionsupporting

confidence: 89%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Profile of People Living with HIV after 24 Weeks of Treatment with Dolutegravir in Kinshasa

Bongenya,

Kabengele,

Sombo

et al. 2023

AID

View full text Add to dashboard Cite

show abstract

“…The inclusion period was from October 4, 2021 to April 4, 2022. Sixteen (16) OTCs were selected because of their accessibility and their expertise in the care of PLHIV on a random basis [9]. The patients included were followed for 6 months in compliance with the schedule promulgated by the National Program for the Fight against HIV/AIDS and Sexually Transmitted Infections (PNLS) [10].…”

Section: Study Design Setting Patients and Samplesmentioning

confidence: 99%

Clinical and Anthropometric Evolution of People Living with Human Immunodeficiency Virus during 6 Months of Dolutegravir Treatment in Kinshasa, Democratic Republic of Congo

Bongenya¹,

Losenga²,

Selenge³

et al. 2023

WJA

Self Cite

View full text Add to dashboard Cite

Background: AntiRetroViral Treatment (ART) remains an important tool for reducing morbidity and mortality and improving the quality of life of people living with the Human Immunodeficiency Virus (PLHIV). Under the pressure of ART, several parameters of PLHIV change and are the subject of different evaluations. Objective: The objective of this work was to study the clinical and anthropometric evolution of PLHIV after 6 months of ART based on Dolutegravir (DTG). Methods: The present study was a non-interventional prospective cohort to assess the clinical and anthropometric evolution of PLHIV after 6 months of ART in the Ambulatory Treatment Center (CTA) for HIV in Kinshasa. The patients included were followed for 6 months in compliance with the schedule promulgated by the National Program. The parameters of interest were: Age, Sex, Marital Status, Weight, Height, Body Mass Index and Clinical Status. Results: On inclusion, 119 patients (56.3% women; 43.7% men) were selected. During the consultation appointments, 42 patients (66.7% women; 33.3% men) were present at M1, 37 patients (70.3% women; 29.7% men) at M3, and 67 patients (61.3% women and 38.7% men) in M6. On inclusion, 41.5% of patients were at Stage 3 and 47.0% had a normal clinical condition.

show abstract

“…The present study is a descriptive cross-sectional study to determine the profile of Opportunistic Infections (OI) among People Living with HIV (PLHIV) who starts ART in HIV Outpatient Treatment Centers (OTC) in Kinshasa. Sixteen (16) OTCs were included in the study because of their expertise in the care of PLHIV and their accessibility [12]. The patient inclusion period was from October 04, 2021 to February 15, 2022.…”

Section: Study Design Patient and Sample Settingmentioning

confidence: 99%

Opportunistic Infections in People Living with Human Immunodeficiency Virus Initiating Antiretroviral Therapy in Kinshasa, Democratic Republic of Congo

Ntumba¹,

Bongenya²,

Losenga³

et al. 2022

AustinJInfectDis

View full text Add to dashboard Cite

Background: Opportunistic infections, which are still a major problem in the care of People Living with HIV (PLHIV), occur in situations of immunosuppression. Objective: The objective of this study was to determine the profile of Opportunistic Infections in People Living with HIV starting Antiretroviral Treatment (ART) in Kinshasa during the Dolutegravir era. Methods: The present study is a descriptive cross-sectional study to determine the profile of OIs among PLHIV starting ART in Outpatient Treatment Centers (OTC) in Kinshasa. Sixteen OTCs had been included in the study. The patient inclusion period in the study was from October 04, 2021 to February 15, 2022. The population of the present study was patients over the age of 18 at inclusion, infected with HIV-1 and starting ART in a selected OTC. Results: 119 patients were included in this study respecting the inclusion criteria. 56.3% of patients included are women. The mean age on D0 is 39.87 ± 12.36 years. The most represented age group is that of 36 to 45 years with 37 patients (31.9%). The Opportunistic Infections most found in these PLHIV are: Malaria with 54 cases (45.4%), Tuberculosis (29.4%) and Cutaneous pruritus (23.5%). Conclusion: In this cohort of patients starting ARV treatment in Kinshasa, the most common opportunistic infections are Malaria, Tuberculosis and Cutaneous Pruritus.

show abstract

Sociodemographic and Anthropometric Profile of People Living with Human Immunodeficiency Virus Starting Treatment in Kinshasa, Democratic Republic of the Congo

Cited by 10 publications

References 0 publications

Profile of People Living with HIV after 24 Weeks of Treatment with Dolutegravir in Kinshasa

Profile of People Living with HIV after 24 Weeks of Treatment with Dolutegravir in Kinshasa

Clinical and Anthropometric Evolution of People Living with Human Immunodeficiency Virus during 6 Months of Dolutegravir Treatment in Kinshasa, Democratic Republic of Congo

Opportunistic Infections in People Living with Human Immunodeficiency Virus Initiating Antiretroviral Therapy in Kinshasa, Democratic Republic of Congo

Contact Info

Product

Resources

About